HEADER IMMUNE SYSTEM 12-JUL-13 4LOK TITLE CRYSTAL STRUCTURE OF MSTING IN COMPLEX WITH C[G(3',5')PA(3',5')P] COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-DI-GMP-BINDING DOMAIN; COMPND 5 SYNONYM: MSTING, ENDOPLASMIC RETICULUM INTERFERON STIMULATOR, ERIS, COMPND 6 MEDIATOR OF IRF3 ACTIVATION, MMITA, TRANSMEMBRANE PROTEIN 173; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: TMEM173, ERIS MITA, MPYS, STING; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INNATE IMMUNITY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.GAO,D.J.PATEL REVDAT 3 28-FEB-24 4LOK 1 REMARK SEQADV REVDAT 2 02-OCT-13 4LOK 1 JRNL REVDAT 1 14-AUG-13 4LOK 0 JRNL AUTH P.GAO,M.ASCANO,T.ZILLINGER,W.WANG,P.DAI,A.A.SERGANOV, JRNL AUTH 2 B.L.GAFFNEY,S.SHUMAN,R.A.JONES,L.DENG,G.HARTMANN,W.BARCHET, JRNL AUTH 3 T.TUSCHL,D.J.PATEL JRNL TITL STRUCTURE-FUNCTION ANALYSIS OF STING ACTIVATION BY JRNL TITL 2 C[G(2',5')PA(3',5')P] AND TARGETING BY ANTIVIRAL DMXAA. JRNL REF CELL(CAMBRIDGE,MASS.) V. 154 748 2013 JRNL REFN ISSN 0092-8674 JRNL PMID 23910378 JRNL DOI 10.1016/J.CELL.2013.07.023 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 20191 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1070 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.07 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.12 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1361 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.23 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 62 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2901 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.56000 REMARK 3 B22 (A**2) : 2.67000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.197 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.297 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3066 ; 0.015 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2884 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4172 ; 1.843 ; 2.012 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6594 ; 1.254 ; 3.011 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 360 ; 6.284 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 156 ;36.324 ;23.462 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 512 ;18.334 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;24.555 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 458 ; 0.122 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3470 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 748 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5950 ;12.145 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 51 ;10.454 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 5970 ;19.322 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4LOK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000080889. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20191 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM FORMATE, 20% PEG3350, PH REMARK 280 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.19250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.10050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.68950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.10050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.19250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.68950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 153 REMARK 465 GLU A 335 REMARK 465 GLU A 336 REMARK 465 LYS A 337 REMARK 465 GLU A 338 REMARK 465 GLU A 339 REMARK 465 VAL A 340 REMARK 465 SER B 153 REMARK 465 VAL B 154 REMARK 465 GLU B 335 REMARK 465 GLU B 336 REMARK 465 LYS B 337 REMARK 465 GLU B 338 REMARK 465 GLU B 339 REMARK 465 VAL B 340 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 231 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG B 231 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 GLN B 272 N - CA - CB ANGL. DEV. = -17.3 DEGREES REMARK 500 ASP B 273 N - CA - C ANGL. DEV. = -17.1 DEGREES REMARK 500 ALA B 274 N - CA - CB ANGL. DEV. = 11.1 DEGREES REMARK 500 ASP B 282 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 GLU B 303 CB - CA - C ANGL. DEV. = 14.1 DEGREES REMARK 500 SER B 304 CB - CA - C ANGL. DEV. = -23.5 DEGREES REMARK 500 SER B 304 N - CA - CB ANGL. DEV. = -14.3 DEGREES REMARK 500 SER B 304 N - CA - C ANGL. DEV. = 16.5 DEGREES REMARK 500 ARG B 305 N - CA - CB ANGL. DEV. = -16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 166 -71.87 -145.72 REMARK 500 ARG A 195 44.29 -108.48 REMARK 500 PHE A 201 78.68 -117.27 REMARK 500 TYR B 166 -67.19 -139.53 REMARK 500 ARG B 195 41.77 -106.61 REMARK 500 SER B 271 -7.30 -50.91 REMARK 500 GLN B 272 -75.64 -120.45 REMARK 500 ASP B 273 116.30 -36.99 REMARK 500 ALA B 274 109.34 -160.04 REMARK 500 PHE B 278 -129.13 52.58 REMARK 500 SER B 279 72.25 55.25 REMARK 500 ASP B 300 -160.73 93.45 REMARK 500 VAL B 301 21.54 46.67 REMARK 500 ASN B 306 31.19 -79.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG B 280 GLU B 281 32.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1YD B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4LOH RELATED DB: PDB REMARK 900 RELATED ID: 4LOI RELATED DB: PDB REMARK 900 RELATED ID: 4LOJ RELATED DB: PDB REMARK 900 RELATED ID: 4LOL RELATED DB: PDB DBREF 4LOK A 154 340 UNP Q3TBT3 STING_MOUSE 154 340 DBREF 4LOK B 154 340 UNP Q3TBT3 STING_MOUSE 154 340 SEQADV 4LOK SER A 153 UNP Q3TBT3 EXPRESSION TAG SEQADV 4LOK SER B 153 UNP Q3TBT3 EXPRESSION TAG SEQRES 1 A 188 SER VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE GLY SEQRES 2 A 188 TYR LEU ARG LEU ILE LEU PRO GLY LEU GLN ALA ARG ILE SEQRES 3 A 188 ARG MET PHE ASN GLN LEU HIS ASN ASN MET LEU SER GLY SEQRES 4 A 188 ALA GLY SER ARG ARG LEU TYR ILE LEU PHE PRO LEU ASP SEQRES 5 A 188 CYS GLY VAL PRO ASP ASN LEU SER VAL VAL ASP PRO ASN SEQRES 6 A 188 ILE ARG PHE ARG ASP MET LEU PRO GLN GLN ASN ILE ASP SEQRES 7 A 188 ARG ALA GLY ILE LYS ASN ARG VAL TYR SER ASN SER VAL SEQRES 8 A 188 TYR GLU ILE LEU GLU ASN GLY GLN PRO ALA GLY VAL CYS SEQRES 9 A 188 ILE LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE ALA SEQRES 10 A 188 MET SER GLN ASP ALA LYS ALA GLY PHE SER ARG GLU ASP SEQRES 11 A 188 ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU GLU SEQRES 12 A 188 GLU ILE LEU GLU ASP VAL PRO GLU SER ARG ASN ASN CYS SEQRES 13 A 188 ARG LEU ILE VAL TYR GLN GLU PRO THR ASP GLY ASN SER SEQRES 14 A 188 PHE SER LEU SER GLN GLU VAL LEU ARG HIS ILE ARG GLN SEQRES 15 A 188 GLU GLU LYS GLU GLU VAL SEQRES 1 B 188 SER VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE GLY SEQRES 2 B 188 TYR LEU ARG LEU ILE LEU PRO GLY LEU GLN ALA ARG ILE SEQRES 3 B 188 ARG MET PHE ASN GLN LEU HIS ASN ASN MET LEU SER GLY SEQRES 4 B 188 ALA GLY SER ARG ARG LEU TYR ILE LEU PHE PRO LEU ASP SEQRES 5 B 188 CYS GLY VAL PRO ASP ASN LEU SER VAL VAL ASP PRO ASN SEQRES 6 B 188 ILE ARG PHE ARG ASP MET LEU PRO GLN GLN ASN ILE ASP SEQRES 7 B 188 ARG ALA GLY ILE LYS ASN ARG VAL TYR SER ASN SER VAL SEQRES 8 B 188 TYR GLU ILE LEU GLU ASN GLY GLN PRO ALA GLY VAL CYS SEQRES 9 B 188 ILE LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE ALA SEQRES 10 B 188 MET SER GLN ASP ALA LYS ALA GLY PHE SER ARG GLU ASP SEQRES 11 B 188 ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU GLU SEQRES 12 B 188 GLU ILE LEU GLU ASP VAL PRO GLU SER ARG ASN ASN CYS SEQRES 13 B 188 ARG LEU ILE VAL TYR GLN GLU PRO THR ASP GLY ASN SER SEQRES 14 B 188 PHE SER LEU SER GLN GLU VAL LEU ARG HIS ILE ARG GLN SEQRES 15 B 188 GLU GLU LYS GLU GLU VAL HET 1YD B 401 90 HETNAM 1YD 2-AMINO-9-[(2R,3R,3AR,5S,7AS,9R,10R,10AR,12R,14AS)-9- HETNAM 2 1YD (6-AMINO-9H-PURIN-9-YL)-3,5,10,12-TETRAHYDROXY-5,12- HETNAM 3 1YD DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9, HETNAM 4 1YD 2,8]TETRAOXADIPHOSPHACYCLODODECIN-2-YL]-1,9-DIHYDRO- HETNAM 5 1YD 6H-PURIN-6-ONE FORMUL 3 1YD C20 H24 N10 O13 P2 FORMUL 4 HOH *139(H2 O) HELIX 1 1 VAL A 154 GLY A 165 1 12 HELIX 2 2 TYR A 166 LEU A 171 1 6 HELIX 3 3 GLY A 173 HIS A 185 1 13 HELIX 4 4 ASN A 210 VAL A 214 5 5 HELIX 5 5 ALA A 261 ASP A 273 1 13 HELIX 6 6 SER A 279 LEU A 298 1 20 HELIX 7 7 GLU A 299 VAL A 301 5 3 HELIX 8 8 GLU A 303 ASN A 307 1 5 HELIX 9 9 SER A 323 GLN A 334 1 12 HELIX 10 10 HIS B 156 TYR B 166 1 11 HELIX 11 11 TYR B 166 LEU B 171 1 6 HELIX 12 12 GLY B 173 HIS B 185 1 13 HELIX 13 13 GLY B 191 ARG B 195 5 5 HELIX 14 14 ASN B 210 ASP B 215 1 6 HELIX 15 15 THR B 262 SER B 271 1 10 HELIX 16 16 GLU B 281 GLU B 299 1 19 HELIX 17 17 SER B 304 ASN B 306 5 3 HELIX 18 18 SER B 323 GLN B 334 1 12 SHEET 1 A 5 ILE A 218 MET A 223 0 SHEET 2 A 5 SER A 242 GLU A 248 -1 O VAL A 243 N ASP A 222 SHEET 3 A 5 GLN A 251 TYR A 260 -1 O GLY A 254 N ILE A 246 SHEET 4 A 5 LEU A 197 PRO A 202 1 N LEU A 200 O GLU A 259 SHEET 5 A 5 CYS A 308 TYR A 313 1 O ILE A 311 N PHE A 201 SHEET 1 B 2 GLN A 227 ARG A 231 0 SHEET 2 B 2 ILE A 234 TYR A 239 -1 O TYR A 239 N GLN A 227 SHEET 1 C 5 ILE B 218 MET B 223 0 SHEET 2 C 5 SER B 242 GLU B 248 -1 O VAL B 243 N ASP B 222 SHEET 3 C 5 GLN B 251 TYR B 260 -1 O GLY B 254 N ILE B 246 SHEET 4 C 5 LEU B 197 PRO B 202 1 N LEU B 200 O GLU B 259 SHEET 5 C 5 CYS B 308 TYR B 313 1 O ILE B 311 N ILE B 199 SHEET 1 D 2 GLN B 227 ARG B 231 0 SHEET 2 D 2 ILE B 234 TYR B 239 -1 O TYR B 239 N GLN B 227 CISPEP 1 ALA B 274 LYS B 275 0 9.71 CISPEP 2 LYS B 275 ALA B 276 0 25.48 SITE 1 AC1 25 TYR A 162 GLY A 165 TYR A 166 ARG A 237 SITE 2 AC1 25 VAL A 238 TYR A 239 THR A 262 PRO A 263 SITE 3 AC1 25 HOH A 413 HOH A 467 TYR B 162 TYR B 166 SITE 4 AC1 25 ILE B 234 ARG B 237 VAL B 238 TYR B 239 SITE 5 AC1 25 GLU B 259 THR B 262 PRO B 263 HOH B 503 SITE 6 AC1 25 HOH B 504 HOH B 549 HOH B 550 HOH B 552 SITE 7 AC1 25 HOH B 553 CRYST1 46.385 47.379 156.201 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021559 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021106 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006402 0.00000